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Processing of Procollagen III by Meprins:
New Players in Extracellular Matrix Assembly?
Daniel Kronenberg1,2,5, Bernd C. Bruns2,5, Catherine Moali1, Sandrine Vadon-Le Goff1, Erwin E. Sterchi3,
Heiko Traupe4, Markus Bo¨hm4, David J.S. Hulmes1, Walter Sto¨cker2 and Christoph Becker-Pauly2
Meprins a and b, a subgroup of zinc metalloproteinases belonging to the astacin family, are known to cleave
components of the extracellular matrix, either during physiological remodeling or in pathological situations. In
this study we present a new role for meprins in matrix assembly, namely the proteolytic processing of
procollagens. Both meprins a and b release the N- and C-propeptides from procollagen III, with such
processing events being critical steps in collagen fibril formation. In addition, both meprins cleave procollagen
III at exactly the same site as the procollagen C-proteinases, including bone morphogenetic protein-1 (BMP-1)
and other members of the tolloid proteinase family. Indeed, cleavage of procollagen III by meprins is more
efficient than by BMP-1. In addition, unlike BMP-1, whose activity is stimulated by procollagen C-proteinase
enhancer proteins (PCPEs), the activity of meprins on procollagen III is diminished by PCPE-1. Finally, following
our earlier observations of meprin expression by human epidermal keratinocytes, meprin a is also shown to
be expressed by human dermal fibroblasts. In the dermis of fibrotic skin (keloids), expression of meprin a
increases and meprin b begins to be detected. Our study suggests that meprins could be important players
in several remodeling processes involving collagen fiber deposition.
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INTRODUCTION
In addition to the nonspecific degradation of protein
substrates, proteolysis has been found to be of pre-eminent
importance in a variety of physiological functions (Overall
and Blobel, 2007; Lopez-Otin and Bond, 2008). In many
cases, proteolytic enzymes have been reported to act as
highly specific scissors, whose actions are fine-tuned with
respect to time and location (Doucet et al., 2008). The
multidomain endopeptidases meprins a and b, members of
the astacin family of zinc metalloproteinases (MEROPS
M12A), are known to be expressed in the brush border
membranes of intestinal and kidney tubules, certain cancer
cells, and intestinal leukocytes (Sterchi et al., 2008). In
addition, differential expression in epidermal layers
suggests a role in epithelial differentiation and proliferation
(Becker-Pauly et al., 2007). Despite these observations, the
physiological functions of meprins a and b remain poorly
understood.
Meprins are membrane-bound proteinases that, in the case
of human meprin a, can be released from the cell surface
after proteolytic cleavage during translocation through the
secretory pathway (Kohler et al., 2000); in addition, human
meprin b can be released from the cell surface by shedding
(Hahn et al., 2003). As such, these proteinases are in contact
with the extracellular matrix (ECM), and several reports
suggest that they are involved in ECM remodeling and tissue
differentiation (Kruse et al., 2004; Sterchi et al., 2008). First,
macrophages from meprin b knockout mice have a reduced
ability to migrate through the ECM (Crisman et al., 2004).
Second, meprin b has been identified as a possible key player
in passive Heymann nephritis, revealing a function in the
physiological turnover of the glomerular basement mem-
brane in rat kidney (Oneda et al., 2008). Similarly, in colon
carcinoma, meprin a is expressed not only apically but also
basolaterally, which may increase the potential of tumor cells
to break through basement membranes as a result of
increased proteolytic activity against ECM proteins (Lottaz
et al., 1999; Rosmann et al., 2002). Finally, compared with
wild-type mice, meprin a knockout mice show decreased
lipopolysaccharide-induced injury in kidney tubules, subse-
quently revealing the ability of meprin a to cleave adhesion
molecules (Yura et al., 2009). The latter has also been
confirmed for meprin b in cell culture studies (Carmago et al.,
2002; Becker-Pauly et al., 2007; Huguenin et al., 2008).
Nevertheless, ECM remodeling by meprin metalloproteinases
is not yet understood on the molecular level.
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Meprins a and b differ dramatically not only in their
quaternary structure (Becker et al., 2003; Bertenshaw et al.,
2003; Becker-Pauly et al., 2009), but also in their cleavage
specificity. Although meprin a prefers uncharged residues at
the P10 position in the cleavage site, meprin b shows strong
specificity for negatively charged residues at this position
(Kruse et al., 2004; Sterchi et al., 2008). Thus, meprin b has a
specificity similar to the astacin proteinases of the tolloid
subfamily (e.g., bone morphogenetic protein-1 (BMP-1)), for
which almost all known substrates have an aspartate residue
at P10 (Hopkins et al., 2007). This leads to the question
of whether meprins can also cleave substrates of tolloid
proteinases, such as fibrillar procollagens.
In this study we show that both meprins a and b are
capable of efficiently releasing the N- and C-propeptides
from procollagen III. C-terminal cleavage is shown to occur at
exactly the same site as with BMP-1 but, unlike BMP-1,
whose activity is stimulated by procollagen C-proteinase
(PCP) enhancer-1 (PCPE-1) (Moali et al., 2005), meprins are
inhibited in the presence of PCPE-1. Finally, we show for the
first time that meprin a is expressed by human dermal
fibroblasts and that expression of meprin a in the dermis
increases in fibrotic conditions (keloid), in which meprin b
also begins to be detected.
RESULTS
Procollagen III is a substrate for meprins a and b
Recombinant procollagen III was first incubated at 37 1C in
the presence of meprins a and b (Figure 1a). In both cases,
the starting material was cleaved and shorter products
were observed by SDS-PAGE. When these products were
compared with the products obtained in the presence of
BMP-1, the prototypical PCP, and with human collagen III
pepsin extracted from placenta (BD Biosciences, Le Pont de
Claix, France), we observed that the main cleavage product
migrated faster than pN-collagen III obtained with BMP-1 but
slightly slower than the commercial collagen III (which lacks
the N- and C-telopeptides). This product was analyzed by mass
spectrometry after trypsinization (liquid chromatography-
tandem mass spectrometry) and was found to correspond to
the long triple helix (45% sequence coverage with peptides
identified with 495% confidence for meprin a and 44%
sequence coverage for meprin b; data not shown). Unfortu-
nately, all attempts to determine the N-terminal sequences of
this product failed.
In contrast, we could more easily study the C-terminal
processing of procollagen III by meprins using tools devel-
oped previously. In particular, we used a mini-procollagen III
substrate (Moali et al., 2005) that is made up of an N-terminal
myc tag, the last 33 Gly-X-Y triplets of the triple helical
region, the C-telopeptide, and the C-propeptide region of
the full-length molecule (Figure 1b). Incubation of mini-
procollagen III with meprins a or b led to cleavage of the
substrate, resulting in a similar cleavage pattern to that
obtained with BMP-1 (Figure 1c). The band approximately
100 kDa corresponds to the C-propeptide trimer of pro-
collagen III under nonreducing conditions (Figure 1b), which
has a theoretical molecular mass of 82,509Da without
glycosylation. N-terminal sequencing of this cleavage
product, using either meprin a or b, revealed the sequence
DEPMDF that corresponds exactly to the cleavage site
identified for BMP-1. As the N-terminal product is often
difficult to visualize by SDS-PAGE because of inefficient
staining with conventional techniques, we also analyzed
cleavage products by western blotting, using anti-
bodies directed against the N-terminal myc tag in mini-
procollagen III. In the presence of meprin b, a 45-kDa
fragment corresponding to the intact N-terminal fragment
(c-myc tag, triple helix, and C-telopeptide, Figure 1d) could
also be detected. Interestingly, this band was not observed
after incubation with meprin a (Figure 1d). A closer look
at the junction of the c-myc-tag and the triple-helical region
revealed several potential cleavage sites for meprin a
(data not shown). Hence, we assume that the c-myc-tag
was cleaved off by the proteinase, preventing detection with
the corresponding antibody.
Meprins are more efficient PCPs than BMP-1
To quantify meprin activity on mini-procollagen III, the extent
of cleavage was measured by densitometry of gels stained
with SYPRO Ruby (Sigma-Aldrich, Munich, Germany)
(Figure 2a). When the amount of C-propeptide trimer
released was expressed as a percentage of the total
conversion to the C-propeptide, both meprins a and b
showed higher activities than an equimolar amount of
BMP-1. Even in the presence of an optimum concentration
of PCPE-1 for stimulating BMP-1 activity (1:1 molar ratio with
respect to substrate), the activities of meprins a and b (in the
absence of PCPE-1) were still approximately 3-fold higher.
To characterize more precisely the kinetics of the three
enzymes, the cleavage of fluorescent mini-procollagen III
(Kronenberg et al., 2009) was then monitored as a function of
time (Figure 2b). Fitting the curves with the simplified
integrated Michaelis–Menten equation (see Materials and
Methods) gives an estimation of the kinetic parameters
of the enzymes, and shows that indeed meprins are
more efficient than BMP-1 in cleaving fluorescent mini-
procollagen III (kcat/KM ratios of 2.5±0.5 105 M1 s1,
1.1±0.3105 M1 s1, and 0.35±0.2105 M1 s1 for
meprin a, meprin b, and BMP-1, respectively).
PCPE-1 protects procollagen from cleavage by meprins
Interestingly, when meprins were incubated with mini-
procollagen III in the presence of PCPE-1, the activities of
both meprins a and b were less than in the absence of PCPE-1
(Figure 2a). Thus, in contrast to BMP-1, which is stimulated
several fold by PCPE-1 (Ricard-Blum et al., 2002; Moali et al.,
2005), meprins are inhibited in the presence of this tolloid
activator. This inhibitory effect of PCPE-1 was measured
over a range of concentrations, and was found to increase in
a dose-dependent manner (Figure 2c).
PCPE is a substrate for meprins a and b
To test whether the enhancer was diminishing meprin activity
by acting as an alternative substrate, we incubated meprins
a and b directly with PCPE-1. This resulted in a distinct
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cleavage pattern, with cleavage products in the region of 30
and 15 kDa (Figure 3a). To determine the site(s) of cleavage,
we incubated meprins with PCPE-1 fragments, either the
CUB1CUB2 fragment, which is known to be sufficient for
enhancing activity (Hulmes et al., 1997), or the CUB2NTR
region, which has no effect on BMP-1 activity (Kronenberg
et al., 2009). As also shown in Figure 3a, CUB1CUB2 was not
affected by incubation with meprins a or b. In contrast, both
proteinases cleaved CUB2NTR, resulting in similar fragments
in the region of the NTR domain as with full-length PCPE-1.
These observations therefore localize the site(s) of meprin
cleavage to the linker between the CUB2 and NTR domains
(Figure 3a and d). N-terminal sequencing of the products of
cleavage by meprin b showed one of these sites to be at
ESPSAP, some 10 residues before the cysteine at the start of
the NTR domain.
In view of these observations, we sought to determine
whether these fragments of PCPE-1 were capable of dimi-
nishing meprin activity (Figure 3b). The CUB1CUB2 fragment
was equally effective as the full-length protein in reducing the
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Figure 1. Cleavage of procollagen III and mini-procollagen III by meprins. (a) Cleavage of procollagen III by bone morphogenetic protein-1 (BMP-1) and
meprins a and b. Mature collagen III produced by meprin cleavage migrates slower than commercially obtained pepsin-extracted placenta collagen III
(pl. coll III; right gel). Analysis by 6–7.5% SDS-PAGE in reducing conditions, and staining with Coomassie Brilliant Blue. (b) Structure of mini-procollagen III
(Moali et al., 2005) showing the N-terminal c-myc tag (myc), the triple-helical region, the C-telopeptide (telo), and the C-terminal propeptide (CP III).
The arrow indicates the BMP-1 cleavage site. (c, d) Cleavage of mini-procollagen III by BMP-1 and meprins a and b. Analysis by 8% SDS-PAGE under
nonreducing conditions, followed by staining with (c) SYPRO Ruby or (d) western blotting using anti-c-myc antibodies. Asterisks indicate the bands analyzed by
N-terminal sequencing.
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activities of both meprins a and b on mini-procollagen III. In
contrast, the CUB2NTR fragment was not a potent inhibitor of
meprin activity on mini-procollagen III. These observations
show that acting as an alternative substrate is not the
explanation for the effect of PCPE-1 on meprin activity, as
the CUB1CUB2 fragment, which is not a substrate, is equally
effective. In addition, CUB1CUB2, but not CUB2NTR, shows
PCP-enhancing activity with BMP-1 (Kronenberg et al.,
2009), most likely mainly by binding to the substrate. These
observations point to a mechanism by which binding of the
CUB1CUB2 region to mini-procollagen III prevents access of
meprins to the cleavage site. This mechanism is supported by
the observation that an inactive mutant of PCPE-1, containing
a F90A mutation in the CUB1 domain (Blanc et al.,
2007), had no effect on the activities of either meprin a or b
(Figure 3c). Unlike wild-type PCPE-1, this mutant does not
bind to mini-procollagen III (Blanc et al., 2007), although it is
cleaved by meprins in the CUB2NTR linker (Figure 3c).
Meprins are expressed by human fibroblasts
As shown in Figure 4, we found weak but clear expression of
meprin a in healthy dermis (Figure 4a, white arrows). This
was confirmed by reverse transcriptase-PCR revealing meprin
a to be expressed by human adult primary dermal fibroblasts
(Figure 4g), and also in normal human dermis (data not
shown). These cells are the main source of fibrillar collagens
in skin (expression of collagen III is shown in Figure 4g).
Moreover, a striking increase in meprin a expression within
the dermis was observed under pathological conditions in
fibrotic skin (keloid; Figure 4c and e, the latter showing the
deeper dermal layers). This probably reflects an increased
number of fibroblasts, but may also contribute to the
increased amount of collagen deposition, through the
mechanisms described above. Whether the accumulation of
meprin a at the basolateral side of keratinocytes (Figure 4c,
red arrow) promotes the degradation of the basement
membrane, such as in colon cancer (Lottaz et al., 1999),
requires further investigation.
In the fibroblasts of healthy skin, meprin b could not be
detected either by immunofluorescence microscopy or by
reverse transcriptase-PCR (Figure 4b and g, respectively). The
thickened epidermis of fibrotic skin revealed a more diffuse
distribution of meprin b within the epidermis, although with a
preference for keratinocytes of the stratum granulosum. In
addition, in fibrotic skin, a signal could be observed within
the dermis (Figure 4d), especially within the deeper layers
(Figure 4f), and was confirmed by reverse transcriptase-PCR
(Figure 4g).
DISCUSSION
Up until now, three groups of proteinases have been
implicated in the maturation of the fibrillar procollagens (I,
II, III, V, and IX): the tolloid proteinases (including BMP-1),
the furin-like proprotein convertases, and the ADAMTSs
(a disintegrin and metalloprotease with thrombospondin-like
motifs). In general, tolloid proteinases are involved in
C-terminal processing, and ADAMTS-2, 3, and 14 in
N-terminal processing, whereas in the case of the minor
fibrillar collagens (V and XI), tolloid proteinases and furin-like
proprotein convertases are also involved in N- and
C-terminal processing, respectively (Hopkins et al., 2007;
Moali and Hulmes, 2009). In this study we show that meprins
a and b are potential players in procollagen processing, both
at N- and C-terminal ends. Importantly, both are able to
specifically release the C-propeptide of procollagen III,
in vitro, at exactly the same site as BMP-1. Although
N-terminal maturation requires further characterization, it
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Figure 2. Relative C-proteinase activities of BMP-1 and meprins in the
presence and absence of PCPE-1. (a) Quantitation by SYPRO Ruby staining
after 8% SDS-PAGE. For each assay, 15 nM proteinase was incubated
with 164 nM mini-procollagen III with or without 164 nM PCPE-1. Activity
is expressed as percentage of total conversion of substrate. (b) Quantitation
using fluorescent mini-procollagen III, 5.3 nM proteinase, and 150 nM
substrate, and then SDS-PAGE (4–20% acrylamide) and densitometry.
The amount of product released (P, complete conversion ¼ 150nM) is
shown as a function of time. Curves fitted using the integrated form of the
Michaelis–Menten equation. (c) Effects of increasing concentrations of PCPE-1
on meprin cleavage of mini-procollagen III. Up and down arrowheads
indicate mini-procollagen III and CPIII trimer, respectively (Figure 1b).
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seems unlikely that meprins cleave at the same PkQ site as
the ADAMTSs. Given the important role played by the
telopeptides in the control of collagen fibrillogenesis
(Hulmes, 2008), it is possible that slight differences in N-
terminal processing might lead to subtle changes in fibril
formation and hence possible functional consequences.
In this study we have used procollagen III instead of
procollagen I, although the latter is the most abundant
fibrillar collagen in human skin. However, collagen III is an
important biomarker for skin fibrosis (Busquets et al., 2010).
In addition, procollagen III is a well-established substrate
used in past biochemical assays characterizing PCPE and
BMP-1 (Moali et al., 2005; Kronenberg et al., 2009). With
regard to C-terminal processing of the other fibrillar
procollagens, given the sequence conservation in the region
of the cleavage site, it seems likely that meprins may also
have a role, although this remains to be shown. Particularly
striking was the efficiency of processing of procollagen III by
both meprins, which seems to be greater than that of BMP-1,
even in the presence of saturating amounts of PCPE-1.
Surprisingly, although BMP-1 activity was strongly
enhanced by PCPE-1, as expected (Moschcovich et al.,
2001), the latter had an inhibitory effect on meprin activity,
on a mini-procollagen III substrate. Using different fragments
as well as a site-directed inactive mutant of PCPE-1, we
showed that this was because of blocking of the cleavage
site by PCPE-1 binding (through its CUB1CUB2 region) to the
substrate, and not by acting as an alternative substrate.
Importantly, cleavage of PCPE-1 by meprins in the CUB2NTR
linker region had no effect on PCPE-1 activity, for which
an intact CUB1CUB2 region is a necessary and sufficient
condition (Kronenberg et al., 2009). These observations
suggest the intriguing possibility that PCPE-1 might control
the traffic between alternative processing activities (tolloids
or meprins) in different physiological contexts.
Although we have shown that meprins a and b are capable
of removing the propeptides from procollagen III in vitro, the
(patho)physiological relevance of these observations will
depend on their localization relative to procollagens in vivo,
as well as on their status regarding activity (presence of
inhibitors or enhancers, competition with other proteinases,
interactions with other matrix components, and so on). In a
previous study on human skin (Becker-Pauly et al., 2007), we
detected meprins a and b in the keratinocytes of the stratum
basale and stratum granulosum, respectively. However, as
fibrillar collagens are not found in these regions, these data
provided no evidence for an interaction with meprins in vivo.
In this study we show that meprin a is expressed by primary
human fibroblasts, along with procollagen III and BMP-1, and
is found in normal dermis, whereas meprin b is only expres-
sed in the dermis under pathological conditions (keloid)
along with an apparent increase in expression of meprin a.
These observations show that procollagens and meprins
are indeed likely to encounter one another in vivo, parti-
cularly in pathological situations. In this regard, meprins
being transmembrane proteins, it will be important to
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Figure 3. Cleavage of procollagen C-proteinase enhancer-1 (PCPE-1) and effects on meprin activity. (a) Effects of meprins on PCPE-1 and its truncated
forms CUB1CUB2 and CUB2NTR. Analysis by 12% SDS-PAGE, non-reducing conditions, Coomassie Brilliant Blue staining. (b, c) Influence of PCPE-1,
its truncated forms, and the inactive F/A mutant on meprin C-proteinase activity. The band migrating slightly faster than PCPE-1 in lane 4 of c corresponds
to the N-terminal region of mini-procollagen III released by proteinase cleavage. This band is absent from lane 1 as a result of additional cleavage in the junction
between the c-myc tag and the triple helix (d), which also affects the migration of the mini-procollagen III substrate. Analysis by 8% SDS-PAGE, Coomassie
Brilliant Blue staining. Asterisks indicate bands analyzed by N-terminal sequencing.
www.jidonline.org 2731
D Kronenberg et al.
Procollagen Processing by Meprins
α ns β ns
α fs β fs
α fs β fs
HDFa
GA
PD
H
Me
p α
Me
p β
BM
P-1
Co
ll II
I
GA
PD
H
Me
p α
Me
p β
BM
P-1
Co
ll II
I
Keloid dermis
a b
c d
e
g
f
Figure 4. Distribution of meprins in normal and fibrotic human skin. In normal skin, meprins (a) a and (b) b are expressed in the epidermis, as well as meprin a
(a, white arrows), but not meprin b (b), in the dermis, as confirmed by (g) reverse transcriptase PCR (RT-PCR). In fibrotic skin (keloid), meprin a expression
increases in the dermis, in both superficial (c; white arrows) and deeper (e) layers, along with increased expression in the basolateral epidermis (c; red arrow).
Here also, meprin b is detected in the dermis (d, white arrow; g), particularly in the deeper layers (f), and there is increased expression in the epidermis,
particularly in the superficial zone. Bar¼100 mm. fs, fibrotic skin; HDFa, primary human adult dermal fibroblast; ns, normal skin.
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determine whether they are active in procollagen processing
at the cell surface or after shedding into the ECM.
Previous studies (Pappano et al., 2003), using mouse
embryo fibroblasts from Bmp1/ Tll1/ mice, have shown
the importance of tolloid proteinases in procollagen proces-
sing in cell culture. Nevertheless, in these studies, some fully
processed procollagen I was detected in the ECM associated
with the Bmp1/ Tll1/ mouse embryo fibroblast cell
layers. As suggested by Pappano et al. (2003), this might
be attributable to the activity of mTll-2. However, the
data presented in this study suggest the alternative hypothesis
that it might also be because of the action of meprins.
Data from knockout mouse embryo fibroblasts should be
interpreted with caution for several reasons. First, mouse
embryonic fibroblast data may not be transposable to
human adult tissue. We do not know, for example, how the
relative expression levels, by fibroblasts, of meprins and
tolloids, vary as a function of age. Furthermore, proteinase
and collagen expression by fibroblasts is known to be
influenced by the presence of keratinocytes; co-culturing
keloid keratinocytes with normal fibroblasts, for example,
leads to altered collagen deposition (Lim et al., 2002;
Wall et al., 2009). Finally, the presence of serum in some
of the experiments with the fibroblast culture model
complicates the situation, QJ;as this contains a2-macroglo-
bulin, which inhibits BMP-1 (Zhang et al., 2006), as well
as other components that are known to inhibit meprins
(Hirano et al., 2005).
In conclusion, the data presented in this study suggest a
role for meprins in ECM assembly. The inhibitory effect of
PCPE-1 and the increased expression of meprins by fibro-
blasts in keloid tissue suggests that meprins may be involved
in C-terminal procollagen processing particularly in patholo-
gical situations, because of altered epithelial–mesenchymal
cell interactions, or during the early stages of wound repair,
when there is a need to rapidly deposit a matrix that
subsequently undergoes further remodeling involving tolloid
proteinases. Further examination of all the partners involved
will be required to test these hypotheses.
MATERIALS AND METHODS
Patients
This study was approved by the institutional review board of the
University Hospital of Mu¨nster. The Declaration of Helsinki
Principles was followed and all patients enrolled gave their written,
informed consent. Skin samples from patients with keloids were
obtained by routine shave excisions before injection with topical
corticosteroids for cosmetic reasons.
Protein expression and purification
Recombinant human meprins a and b (extracellular domains)
were expressed in baculovirus-infected insect cells and purified as
described (Becker et al., 2003; Becker-Pauly et al., 2007). Full-length
human BMP-1-FLAG, procollagen III, and a short form of procolla-
gen III (mini-procollagen III), were expressed in HEK 293-EBNA cells
(Moali et al., 2005; Blanc et al., 2007). Recombinant human PCPE-1
with an 8-histidine C-terminal tag, its inactive F90A mutant, and
its CUB2-NTR fragment were also expressed in HEK 293-EBNA
cells (Blanc et al., 2007; Kronenberg et al., 2009), whereas the
CUB1CUB2 fragment was prepared by limited trypsinolysis of the
full-length PCPE-1 (Kronenberg et al., 2009). Fluorescent mini-
procollagen III, labeled with DyLight 633 (Thermo Scientific, Bonn,
Germany) was prepared as described previously (Kronenberg et al.,
2009).
Proteolytic activity against procollagen III, mini-procollagen III,
and PCPE-1
For activity assays, mini-procollagen III (330 nM) was incubated for
30minutes at 37 1C with 15 nM proteinase in 50 ml assay buffer
(50mM Tris pH 7.4, 150mM NaCl, 5mM CaCl2, and 0.02% Brij35).
When present, PCPE-1 was added at equimolar concentrations (with
respect to the substrate) and up to 2.5 mM in the case of meprins.
Because of its higher sensitivity, the quantitation with SYPRO Ruby
was performed with only 164 nM mini-procollagen III and PCPE-1 in
the assay, with incubation for 15minutes. To study proteolytic
activity of meprins on PCPE-1, 2 mg of PCPE-1 or its truncated forms
were incubated with 15 nM proteinase for 1 hour in a total volume of
50 ml. To test the influence of different PCPE-1 fragments on meprin
activity, 2mg of each fragment was first preincubated with 15 nM
enzyme for 1 hour, before adding substrate. For cleavage of
full-length procollagen III, 288 nM procollagen was incubated with
15 nM proteinase for 1 hour. All activity assays were performed
at 37 1C in the assay buffer described above.
For quantitation of C-proteinase activity using fluorescent mini-
procollagen III, substrate (150 nM) was incubated in black Eppendorf
tubes at 37 1C with 5.3 nM proteinase in 100ml assay buffer (50mM
Hepes pH 7.4, 150mM NaCl, 5mM CaCl2, and 0.02% Brij35).
Aliquots of 10 ml were taken at the indicated time points, then added
to 10 ml of Laemmli buffer (without bromophenol blue) and
immediately boiled for 5minutes at 100 1C. Samples were then
loaded onto 4–20% gradient acrylamide precast gels (Bio-Rad,
Munich, Germany), run in the dark. Protein bands were analyzed
using a fluorescence gel reader (STORM 860, GE Healthcare,
Munich, Germany) using red laser excitation (lex¼ 630nm) and
ImageQuant 5.2 for quantitation. Experiments were performed in
triplicate. Product formation was plotted against time, and estimates
of kcat/KM were derived from curves fitted by nonlinear regression
using the simplified integrated Michaelis–Menten equation
P¼ S0 (1exp(Kt)), in which K¼ kcat/KM E; P represents
product concentration, E the enzyme concentration, and S0 the
initial substrate concentration (Devel et al., 2006); fit carried out
using Prism 5 from GraphPad Software).
SDS-PAGE, western blotting, and sequencing
In vitro assays containing mini-procollagen III and PCPE-1 were first
precipitated with 10% trichloroacetic acid/acetone, resuspended in
7.5 ml 8M urea, and heated at 100 1C for 5minutes before addition of
sample buffer. Proteins were visualized with Coomassie Brilliant
Blue G-250, EZBlue, or SYPRO Ruby (all from Sigma-Aldrich).
For the latter, the signal was detected with a Molecular Dynamics
STORM 860 Molecular Imager using the blue laser (lex¼ 450 nm)
for fluorescence excitation, followed by protein quantitation using
ImageQuant 5.2 software.
For detection of mini-procollagen III using polyclonal rabbit anti-
c-myc antibodies (Sigma-Aldrich; diluted 1:7500) proteins were
separated by SDS-PAGE and transferred to polyvinylidene fluoride
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membranes (Immobilon P, Millipore, Schwalbach, Germany)
by electroblotting. The signal was detected using RotiLumin
(Roth, Karlsruhe, Germany) and X-ray film (Hyperfilm ECL, GE
Healthcare), following the manufacturer’s instructions. Magic Mark
XP (Invitrogen, Karlsruhe, Germany) was used as molecular weight
markers.
For N-terminal sequencing, proteins were blotted onto poly-
vinylidene fluoride membranes, stained with Coomassie Brilliant
blue, and then sequenced at the protein microsequencing center of
the Institut Fe´de´ratif de Recherche (IFR) 128 (Lyon, France).
RNA isolation and reverse transcriptase-PCR
All materials for RNA isolation and reverse transcription were
obtained from Peqlab (Erlangen, Germany). Reagents for PCR were
obtained from New England Biolabs (Frankfurt, Germany). Primary
human dermal fibroblasts, isolated from adult skin (Invitrogen), were
cultured following the manufacturer’s instructions. Total RNA was
isolated from adherent fibroblasts or normal (n¼ 6) and keloid
dermis (n¼ 7) using the peqGOLD Total RNA Kit. Equal amounts of
RNA (1 mg) were transcribed into complementary DNA in 25 ml
reaction mixtures using Moloney Murine Leukemia Virus-reverse
transcriptase (200Uml–1), nonspecific oligo d(T) primers (10mM;
Roth), additional RNase inhibitor (30Uml–1), and dNTPs (200 mM).
After transcription, 1ml of the newly synthesized complementary
DNA was used as a template for PCR, which was performed
with 2.5U of Taq-Polymerase (New England Biolabs), 200 mM dNTP
mix, and 0.2 pM of each primer (sense and antisense). Primer
sequences are listed in Supplementary Table S1 online.
After initial denaturation at 95 1C for 5minutes, PCRs were
carried out over 30 cycles of 94 1C for 60 seconds, 55 1C for
30 seconds, and 72 1C for 60 seconds. Equal amounts of PCR
products were visualized by separation on 1% agarose gels
containing 0.04% ethidium bromide.
Immunofluorescence analysis
Immunofluorescence assays were performed as previously described
(Becker-Pauly et al., 2007). Cryosections from fibrotic (keloids, n¼ 7)
and healthy (n¼ 15) skin were analyzed using rabbit polyclonal anti-
meprin a- or b-specific antibodies (Becker-Pauly et al., 2007). Cell
nuclei were stained using 4,6-diamidino-2-phenylindole.
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